Kush M Parmar
Overview
Dr. Parmar serves as a Director on the Boards of Akouos (NASDAQ: AKUS), Ensoma, Entrada (NASDAQ: TRDA), GlycoEra, Homology (NASDAQ: FIXX), Rallybio (NASDAQ: RLYB) and Vor Biopharma (NASDAQ: VOR). Prior to 5AM, Dr. Parmar was at Harvard Medical School, where he was an NIH-sponsored M.D./Ph.D. Physician Scientist Fellow in the Harvard-MIT Health Sciences and Technology Program. He completed clinical clerkships at the Massachusetts General & Brigham and Women’s Hospitals. At Princeton University, Dr. Parmar worked on developmental genetics with Eric F. Wieschaus (Nobel Prize in Medicine in 1995).
Get the full list of 54,000+ investors
Kush M Parmar and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Kush M Parmar
What sectors does Kush M Parmar invest in?
Kush M Parmar invests in BioTech, and is based in Boston, Massachusetts. Kush M Parmar is listed as a investor in the ConnectSafely investor database.
What stage does Kush M Parmar invest at?
Kush M Parmar backs companies at Seed and Series A, writing cheques of $0 - $100K.
Which regions does Kush M Parmar invest in?
Kush M Parmar invests across US/Canada.
How do I contact Kush M Parmar?
Kush M Parmar's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database